Ozempic Rapidly Becoming the Go-To Weight Loss Treatment for Teens

A new study shows GLP-1 drug use, including Ozempic, is rising rapidly among teenagers and young adults, increasingly displacing bariatric surgery as the primary obesity treatment in this age group. The shift is raising questions about the long-term safety of hormonal therapy in young patients. Researchers say the trend is clear and accelerating.